These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1326 related items for PubMed ID: 21289970

  • 1. Therapy of atopic eczema.
    Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.
    GMS Health Technol Assess; 2006 Oct 06; 2():Doc19. PubMed ID: 21289970
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topical tacrolimus for atopic dermatitis.
    Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM.
    Cochrane Database Syst Rev; 2015 Jul 01; 2015(7):CD009864. PubMed ID: 26132597
    [Abstract] [Full Text] [Related]

  • 5. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C, Colquitt JL, Kirby J, Davidson P, Payne E.
    Health Technol Assess; 2004 Nov 01; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y, Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group.
    Pediatrics; 2002 Jul 01; 110(1 Pt 1):e2. PubMed ID: 12093983
    [Abstract] [Full Text] [Related]

  • 7. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2009 Jul 01; 9(27):1-66. PubMed ID: 23074532
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K, Werfel T, Kapp A.
    Am J Clin Dermatol; 2005 Jul 01; 6(2):65-77. PubMed ID: 15799678
    [Abstract] [Full Text] [Related]

  • 9. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ, Karner C, Jhita T, Barton S, Marceniuk G, Yiu ZZN, Wittmann M.
    Health Technol Assess; 2024 Jan 01; 28(4):1-113. PubMed ID: 38343072
    [Abstract] [Full Text] [Related]

  • 10. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
    Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L.
    Health Technol Assess; 2005 Jul 01; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
    [Abstract] [Full Text] [Related]

  • 11. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K, Jarvis B.
    Drugs; 2002 Jul 01; 62(5):817-40. PubMed ID: 11929333
    [Abstract] [Full Text] [Related]

  • 12. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC, Qureshi AA.
    Am J Clin Dermatol; 2012 Apr 01; 13(2):113-23. PubMed ID: 22263704
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W, Kruszewski J, Silny W, Kurzawa R, Czarnecka-Operacz M, Baran E, Szepietowski J, Task Force of the National Specialists on Dermatology, Venereology and Allergology.
    Pol Merkur Lekarski; 2004 Apr 01; 17 Suppl 3():3-15. PubMed ID: 15688665
    [Abstract] [Full Text] [Related]

  • 14. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.
    Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, Vestergaard C, Seneschal J, Werfel T, Cork MJ, Kunz B, Fölster-Holst R, Trzeciak M, Darsow U, Szalai Z, Deleuran M, von Kobyletzki L, Barbarot S, Heratizadeh A, Gieler U, Hijnen DJ, Weidinger S, De Raeve L, Svensson Å, Simon D, Stalder JF, Ring J, European Task Force on Atopic Dermatitis/EADV Eczema Task Force.
    J Eur Acad Dermatol Venereol; 2020 Dec 01; 34(12):2717-2744. PubMed ID: 33205485
    [Abstract] [Full Text] [Related]

  • 15. Systematic review of treatments for atopic eczema.
    Hoare C, Li Wan Po A, Williams H.
    Health Technol Assess; 2000 Dec 01; 4(37):1-191. PubMed ID: 11134919
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC.
    BMJ; 2005 Mar 05; 330(7490):516. PubMed ID: 15731121
    [Abstract] [Full Text] [Related]

  • 17.
    Nankervis H, Thomas KS, Delamere FM, Barbarot S, Rogers NK, Williams HC.
    ; 2016 05 05. PubMed ID: 27280278
    [Abstract] [Full Text] [Related]

  • 18. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K, Jarvis B.
    Am J Clin Dermatol; 2002 05 05; 3(6):435-8. PubMed ID: 12113651
    [Abstract] [Full Text] [Related]

  • 19. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.
    Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, MacDonald M, Wen A, Steen J, Levine M, Pyne L, Schneider L, Chu DK, AAAAI/ACAAI Joint Task Force on Practice Parameters for Atopic Dermatitis Guideline Development Group.
    Lancet Child Adolesc Health; 2023 Jan 05; 7(1):13-25. PubMed ID: 36370744
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Abramovits W, Hung P, Tong KB.
    Am J Clin Dermatol; 2006 Jan 05; 7(4):213-22. PubMed ID: 16901181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.